Bat3 promotes T cell responses and autoimmunity by repressing Tim-3–mediated cell death and exhaustion-Reference-Cited by-同舟云学术

Bat3 promotes T cell responses and autoimmunity by repressing Tim-3–mediated cell death and exhaustion

Published:2012-08-05 Issue:9 Volume:18 Page:1394-1400
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Rangachari Manu,Zhu Chen,Sakuishi Kaori,Xiao Sheng,Karman Jozsef,Chen Andrew,Angin Mathieu,Wakeham Andrew,Greenfield Edward A,Sobel Raymond A,Okada Hitoshi,McKinnon Peter J,Mak Tak W,Addo Marylyn M,Anderson Ana C,Kuchroo Vijay K

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.2871.pdf

Reference46 articles.

1. Dunn, G.P. et al. Interferon-γ and cancer immunoediting. Immunol. Res. 32, 231–245 (2005).

2. Myrmel, H., Ulvestad, E. & Asjo, B. The hepatitis C virus enigma. APMIS 117, 427–439 (2009).

3. Romagnani, S. Th1/Th2 cells. Inflamm. Bowel Dis. 5, 285–294 (1999).

4. Moss, R.B. et al. Th1/Th2 cells in inflammatory disease states: therapeutic implications. Expert Opin. Biol. Ther. 4, 1887–1896 (2004).

5. Monney, L. et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415, 536–541 (2002).

Cited by 304 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FKBP38 deletion exacerbates ConA-induced hepatitis by promoting the immune response through the MCP-1/p38 pathway;International Immunopharmacology;2024-09

2. Advances in immunotherapy for breast cancer and feline mammary carcinoma: From molecular basis to novel therapeutic targets;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

3. TIGIT: Will it be the next star therapeutic target like PD-1 in hematological malignancies?;Critical Reviews in Oncology/Hematology;2024-09

4. Generation and Characterization of Ex Vivo Expanded Tumor-infiltrating Lymphocytes From Renal Cell Carcinoma Tumors for Adoptive Cell Therapy;Journal of Immunotherapy;2024-07-15

5. BAG6 restricts pancreatic cancer progression by suppressing the release of IL33-presenting extracellular vesicles and the activation of mast cells;Cellular & Molecular Immunology;2024-06-28